EF
CLX icon

Empirical Finance’s Clorox CLX Stock Holding History

Empirical Finance’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
11,217
+6,948
+163% +$667K 0.04% 295
2026
Q1 		$442K Sell
4,269
-8
-0.2% -$907 0.02% 429
2025
Q4 		$431K Sell
4,277
-181
-4% -$19.6K 0.02% 425
2025
Q3 		$550K Buy
4,458
+42
+1% +$5.21K 0.03% 415
2025
Q2 		$530K Buy
4,416
+31
+0.7% +$4.14K 0.03% 414
2025
Q1 		$646K Buy
4,385
+159
+4% +$24.3K 0.04% 365
2024
Q4 		$686K Sell
4,226
-48
-1% -$7.85K 0.04% 343
2024
Q3 		$696K Buy
4,274
+93
+2% +$13.8K 0.04% 345
2024
Q2 		$571K Sell
4,181
-276
-6% -$38.3K 0.04% 379
2024
Q1 		$682K Buy
4,457
+152
+4% +$22.7K 0.04% 355
2023
Q4 		$614K Buy
4,305
+30
+0.7% +$4K 0.04% 356
2023
Q3 		$560K Buy
4,275
+404
+10% +$61.4K 0.04% 352
2023
Q2 		$616K Buy
3,871
+424
+12% +$68.4K 0.05% 321
2023
Q1 		$545K Buy
3,447
+178
+5% +$26.7K 0.05% 328
2022
Q4 		$459K Buy
3,269
+246
+8% +$34.9K 0.05% 349
2022
Q3 		$388K Buy
3,023
+485
+19% +$70K 0.05% 340
2022
Q2 		$358K Buy
2,538
+133
+6% +$19K 0.05% 358
2022
Q1 		$334K Buy
2,405
+257
+12% +$39.4K 0.04% 393
2021
Q4 		$375K Buy
2,148
+561
+35% +$93.5K 0.04% 368
2021
Q3 		$263K Buy
1,587
+89
+6% +$15.3K 0.04% 366
2021
Q2 		$270K Buy
1,498
+217
+17% +$39.6K 0.04% 343
2021
Q1 		$259K Hold
1,281
– – 0.05% 290
2020
Q4 		$259K Buy
1,281
+220
+21% +$45.5K 0.05% 290
2020
Q3 		$223K Buy
+1,061
New +$236K 0.05% 263
2017
Q1 		– Sell
-57
Closed -$7K – 176
2016
Q4 		$7K Buy
+57
New +$6.72K ﹤0.01% 453

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Empirical Finance's CLX Position: Q2 2026 in Review

Empirical Finance increased its Clorox (CLX) stake by 163% in Q2 2026, buying an estimated $667K and bringing the position to 11,217 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #295.

Empirical Finance first reported a position in CLX in Q4 2016 and has held it in 25 quarters since. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Empirical Finance held 11,217 shares of Clorox worth $1.07M as of Q2 2026.
  • Empirical Finance bought 6,948 Clorox shares in Q2 2026, an estimated $667K.
  • Clorox made up 0.04% of Empirical Finance's portfolio in Q2 2026, its #295 holding.
  • Empirical Finance first reported a position in Clorox in Q4 2016 and has held it in 25 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.